IP Library Granted Patent US 11,951,039
Granted Patent B2
US 11,951,039 · App. 16/610,888 · Granted Apr 9, 2024

Devices and methods for treating eyelids

Inventors: Craig Michael Litherland (Denver, CO); Edward Jaccoma (Fairfield, CT); Andrew Jaccoma (Belmont, MA)
Assignee: eyeThera LLC
A61F9/00772A61B90/04A61F9/00745A61F9/0079A61B2017/00057A61B2017/00084A61B2017/00424A61B18/08A61B18/12A61B2090/0436A61B2090/0472A61B2090/0481A61B2090/049A61F2009/00861
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,951,039
App. No.
16/610,888
Granted
Apr 9, 2024
Kind
B2
Abstract

An ocular protection device and treatment methods are disclosed. The device has a corneal shield with an attached handle. The handle may be used to move the corneal shield to better protect the eye from various treatment modalities. The handle may also be used to place tension on the eyelid to counteract the forces imposed by a treatment handpiece. A procedure for treating the eye is disclosed where multiple passes with a treatment handpiece cause a gradual increase in the temperature of an eyelid up to a treatment temperature. Once the treatment temperature has been met, occlusions in the Meibomian glands of the eyelid may be expressed. The procedure may be repeated recursively until a desired level of expression has been achieved.

Claims (26)

1. An ocular protection device comprising:

a corneal shield configured to fit underneath eyelids, the corneal shield having an inner surface configured to prevent damage to an eye;

a handle rigidly connected to an outer surface of the corneal shield, the handle configured to protrude between closed eyelids; and

wherein the handle includes a hinge that is offset from the corneal shield, and the handle is sufficiently long to allow an operator to control the corneal shield via the handle and wherein the hinge permits the operator to have an unobstructed view and access to the eyelids while maintaining control of the corneal shield.

2. The device of claim 1 , wherein the handle has a length of at least about 25 mm.

3. The device of claim 1 , wherein the handle and shield are integrally formed.

4. The device of claim 1 , wherein the hinge is offset from the corneal shield by at least 15 mm.

5. The device of claim 1 , wherein the hinge is a living hinge.

6. The device of claim 1 , wherein the hinge comprises a junction piece that joins sections of the handle together.

7. The device of claim 6 , wherein the hinge is a living hinge.

8. The device of claim 6 , wherein the junction piece is an overmold that connects the handle sections.

9. The device of claim 1 , wherein the shield is made of a material that substantially insulates against electrical and thermal energy to protect the eye.

10. A method for treating Meibomian gland dysfunction comprising the steps of:

shielding a surface of an eye using an ocular protection device comprising a corneal shield and a handle which allows for manipulation of the corneal shield on the eye;

heating the outside of an eyelid, using a hand-held treatment device, to a temperature to melt, soften, or loosen obstructions in Meibomian glands;

manually applying pressure to the outer surface of the eyelid to express obstructions blocking the glands; and

manually controlling the corneal shield, via the handle, to apply a counterforce to the applied pressure.

11. The method claim 10 , wherein the eyelid is heated by one of radiofrequency energy (RF), intense pulsed light (IPL), thermal conduction, and ultrasonic vibrations.

12. The method of claim 10 , wherein the pressure is in a range of about 0.5 psi to about 10 psi.

13. The method of claim 10 , wherein the pressure is applied in strokes toward the lid margin.

14. The method of claim 10 , further comprising measuring the temperature of the eyelid using at least one temperature sensor, the temperature sensor selected from a group consisting of an infrared temperature sensor, a fiber optic sensor, a thermistor, and a thermocouple.

15. The method of claim 14 , wherein the temperature sensor is located on the treatment device.

16. The method of claim 14 , wherein the temperature is automatically controlled via feedback control.

17. The method of claim 10 , wherein the handle of the device has a hinge which permits movement of the handle to allow access to the eyelid and to allow an operator to control the corneal shield.

18. The method of claim 17 , wherein the hinge is a living hinge.

19. The method of claim 10 , wherein the pressure is applied by the treatment device.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2019
From: LITHERLAND, CRAIG; JACCOMA, EDWARD; JACCOMA, ANDREW
To: EYETHERA LLC
Reel/Frame 050923/0885 →
Continuity (3)
Provisional Application 62572307 · Oct 13, 2017
Provisional Application 62502081 · May 5, 2017
Related Publication 20200069468A1 · Mar 5, 2020